What is Johnson & Johnson's erleada — percent change (as a percent)?

Johnson & Johnson (JNJ) reported erleada — percent change (as a percent) of 53.7% in Q3 2025.

How has Johnson & Johnson's erleada — percent change (as a percent) changed year-over-year?

Johnson & Johnson's erleada — percent change (as a percent) decreased by 28.3% year-over-year, from 74.9% to 53.7%.

What does erleada — percent change (as a percent) mean?

The percentage growth rate of net sales for the ERLEADA product compared to the previous period.

ERLEADA — Percent Change (as a percent)

Products & Services · Percent Change (as a percent)

Johnson & Johnson ERLEADA — Percent Change (as a percent) decreased by 22.2% to 53.7% in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 28.3%, from 74.9% to 53.7%. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityVolatile

First reportedQ2 2021

Last reportedQ3 2025

How to read this metric

A positive percentage indicates accelerating sales growth, whereas a negative percentage suggests a slowdown in demand or market saturation.

Detailed definition

This metric measures the period-over-period percentage growth or decline in net sales for the ERLEADA product line. It s...

Peer comparison

Comparable to year-over-year or quarter-over-quarter growth rates for specific blockbuster drugs reported by peer pharmaceutical firms.

Metric ID: jnj_segment_erleada_percent_change_as_a_percent

Historical Data

14 periods

	Q2 '21	Q3 '21	Q4 '21	Q2 '22	Q3 '22	Q4 '22	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25
Value	126.8%	119.1%	107.2%	73.3%	70.1%	61.3%	107.7%	87.4%	79.1%	90%	74.9%	32.9%	69%	53.7%
QoQ Change	—	-6.1%	-10.0%	-31.6%	-4.4%	-12.6%	+75.7%	-18.8%	-9.5%	+13.8%	-16.8%	-56.1%	+109.7%	-22.2%
YoY Change	—	—	—	-42.2%	-41.1%	-42.8%	+46.9%	+24.7%	—	-16.4%	-14.3%	-58.4%	-23.3%	-28.3%

Range32.9% – 126.8%

CAGR-23.2%

Avg YoY Growth-19.5%

Median YoY Growth-25.8%

Similar Metrics at Other Companies

Eli LillyLLY View metric

Frequently Asked Questions

What is Johnson & Johnson's erleada — percent change (as a percent)?: Johnson & Johnson (JNJ) reported erleada — percent change (as a percent) of 53.7% in Q3 2025.
How has Johnson & Johnson's erleada — percent change (as a percent) changed year-over-year?: Johnson & Johnson's erleada — percent change (as a percent) decreased by 28.3% year-over-year, from 74.9% to 53.7%.
What does erleada — percent change (as a percent) mean?: The percentage growth rate of net sales for the ERLEADA product compared to the previous period.